Search Share Prices

III News - ImmuPharma present product development portfolio and corporate structure overhaul

Tim McCarthy caught up with Proactive London after recently announcing a corporate overhaul aimed at saving £1.1m per ...

Read More »

Synairgen CEO Richard Marsden presents six month progress as COVID-19 treatment trials continue

Synairgen PLC's (LON:SNG) chief executive Richard Marsden talks to Proactive London’s Katie Pilbeam about what has been achieved over the past six months. The Phase III trial of its SNG001 inhaled, ...

Read More »

With piv­otal da­ta on its Covid-19 an­ti­body in hand, As­traZeneca pre­pares for a mad dash to the FDA

A month after revealing that its monoclonal antibody combination was 77% effective at preventing symptomatic Covid-19 compared to placebo, AstraZeneca says it’s headed to the FDA. “We've certainly ...

Read More »

AL Amyloidosis: Alexion, AstraZeneca Rare Disease, takes over Caelum Biosciences, Inc.

AstraZeneca (LON: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced its rare diseases arm Alexion has exercised its option to acquire all remaining equity ...

Read More »

American Portfolios Recognized Five Times in the Inaugural ThinkAdvisor LUMINARIES Recognition Program

AM Eastern Daylight Time The New York-based, privately-held, independent broker/dealer has been included in Investment Advisor magazine's first-ever ThinkAdvisor LUMINARIES Class of 2021 recognition ...

Read More »

Related Share Prices